CYNTHIA OSBORNE, MD
Medical Oncology Physician · DALLAS, TX
Individual Active NPI 1639111503
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 595 | 93,386 | $7,917,314 | $2,284,408 | $1,821,519 |
| 2023 | 533 | 98,953 | $7,281,649 | $2,068,470 | $1,647,082 |
| 2022 | 553 | 104,126 | $7,651,507 | $2,335,518 | $1,878,791 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 12,300 | $56 | $45 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,500 | $0 | $0 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 5,903 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 5,752 | $0 | $0 |
| J9299 | Injection, nivolumab, 1 mg | 4,400 | $31 | $25 |
| J9025 | Injection, azacitidine, 1 mg | 3,645 | $0 | $0 |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 3,240 | $49 | $39 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,546 | $0 | $0 |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 990 | $46 | $37 |
| J2469 | Injection, palonosetron hcl, 25 mcg | 930 | $1 | $1 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 560 | $0 | $0 |
| J0640 | Injection, leucovorin calcium, per 50 mg | 494 | $4 | $4 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | K7854 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Texas
- NPI 1962595090
- NPI 1407898505
- NPI 1821257072
- NPI 1225328743
- NPI 1528591047
- NPI 1326368895
- NPI 1154530830
- NPI 1235171281
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.